Enyo Pharma
Clinical-stage biopharma developing oral vonafexor for chronic kidney disease and Alport syndrome
Highlights
- New on EvolcAdded 2026-11-02
About Enyo Pharma
ENYO Pharma is a clinical-stage biopharmaceutical company developing therapeutics for patients with impaired kidney function. Its lead compound, vonafexor (EYP001), is a synthetic, non-steroidal FXR agonist with fibrolytic and anti-inflammatory properties in the kidney and liver, taken orally once a day.
Vonafexor is in Phase 2 development for Alport syndrome and chronic kidney disease (CKD). The company's pipeline also covers NASH and diabetic kidney disease (DKD).
ENYO Pharma was founded in 2014 and is headquartered in Lyon, France. Jeff George joined as Chairman of the Board in May 2026.
Product: Vonafexor (EYP001), an oral, once-daily small-molecule FXR agonist in Phase 2 clinical development for kidney diseases.
Jobs at Enyo Pharma
Leadership
- Jacky Vonderscher · Co-founder and Chief Executive OfficerSource: company website
More biotech & pharma companies
Ephyla
Biotech cosmetic active ingredient development for cosmetics and dermocosmetics companiesNew on EvolcEpigene Labs
Oncology data and bioinformatics tools for biopharma researchers developing precision cancer therapiesNew on EvolcEverzom
Develops exosome-based therapeutics and biomanufacturing for regenerative medicine and biotech partnersNew on EvolcFabentech
Develops antibody-based emergency treatments for governments and health organizations facing biological threatsNew on EvolcFermentalg
Microalgae-derived ingredients for nutrition, wellness and pet health companiesNew on EvolcGenclis
Biotechnology company developing RNA-derived therapeutics for drug discovery and developmentNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.